Related Experiment Video
Updated: Oct 11, 2025

A Quantitative Detection Method for MicroRNAs in the Kidney of an Ischemic Kidney Injury Mouse Model
Published on: September 11, 2020
MicroRNA expression profiling in acute kidney injury
Akinori Aomatsu1, Shohei Kaneko2, Katsunori Yanai2
1Division of Nephrology, First Department of Integrated Medicine, Saitama Medical Center, Jichi Medical University, Saitama, Japan; Division of Intensive Care Unit, First Department of Integrated Medicine, Saitama Medical Center, Jichi Medical University, Saitama, Japan.
Abstract:
The aim of this study was to identify miRNAs that regulate AKI and develop their applications as diagnostic biomarkers and therapeutic agents. First, kidney tissues from two different AKI mouse models, namely, AKI induced by the administration of lipopolysaccharide (LPS) causing sepsis (LPS-AKI mice) and AKI induced by renal ischemia-reperfusion injury (IRI-AKI mice), were exhaustively screened for their changes of miRNA expression compared with that of control mice by microarray analysis followed by quantitative RT-PCR. The initial profiling newly identified miRNA-5100, whose expression levels significantly decreased in kidneys in both LPS-AKI mice and IRI-AKI mice. Next, the administration of miRNA-5100-mimic conjugated with a nonviral vector, polyethylenimine nanoparticles (PEI-NPs), via the tail vein significantly induced miRNA-5100 overexpression in the kidney and prevented the development of IRI-AKI mice by inhibiting several apoptosis pathways in vivo. Furthermore, serum levels of miRNA-5100 in patients with AKI were identified as significantly lower than those of healthy subjects. ROC analysis showed that the serum expression level of miRNA-5100 can identify AKI (cut-off value 0.14, AUC 0.96, sensitivity 1.00, specificity 0.833, p<0.05). These results suggest that miRNA-5100 regulates AKI and may be useful as a novel diagnostic biomarker and therapeutic target for AKI.
Insights
Researchers identified miRNA-5100 as a key regulator of acute kidney injury (AKI). Lowered miRNA-5100 levels in AKI patients suggest its potential as a diagnostic biomarker and therapeutic target.
Area of Science:
- Biochemistry
- Molecular Biology
- Nephrology
Background:
- Acute kidney injury (AKI) is a critical clinical condition with limited diagnostic and therapeutic options.
- MicroRNAs (miRNAs) are emerging as key regulators in various biological processes, including kidney injury.
Purpose of the Study:
- To identify novel miRNAs involved in AKI pathogenesis.
- To explore the diagnostic and therapeutic potential of identified miRNAs in AKI.
Main Methods:
- Microarray analysis and quantitative RT-PCR were used to screen miRNA expression in two mouse models of AKI (LPS-induced and IRI-induced).
- miRNA-5100 mimic conjugated with polyethylenimine nanoparticles (PEI-NPs) was administered to investigate therapeutic effects in vivo.
- Serum miRNA levels were analyzed in AKI patients using ROC analysis.
Main Results:
- miRNA-5100 expression was significantly decreased in the kidneys of both AKI mouse models.
- Overexpression of miRNA-5100 using PEI-NPs inhibited apoptosis pathways and protected against renal ischemia-reperfusion injury (IRI-AKI) in mice.
- Serum levels of miRNA-5100 were significantly lower in AKI patients compared to healthy subjects.
- Serum miRNA-5100 demonstrated high accuracy in diagnosing AKI (AUC=0.96).
Conclusions:
- miRNA-5100 plays a regulatory role in AKI.
- miRNA-5100 is a promising diagnostic biomarker for AKI.
- miRNA-5100 represents a potential therapeutic target for AKI treatment.
Related Concept Videos
Acute Kidney Injury II: Pathophysiology
Acute Kidney Injury I: Introduction
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury III: Clinical Manifestations
Acute Kidney Injury V: Interprofessional Care
Acute Kidney Injury VI: Nursing Management

